U.S. market Closed. Opens in 16 hours 55 minutes

CPRX | Catalyst Pharmaceuticals, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for CPRX we got that it has strong fundamentals where Valuation is considered to be slightly undervalued, Profitability is wealthy, Growth is exceptionally good and Health is confidently strong.

Valuation (67%)

Company Industry
P/E Ratio (TTM) 35.06 -15.40
PEG Ratio (TTM) 0.81 -1.28
P/S Ratio (TTM) 5.52 47.91
P/B Ratio (TTM) 3.93 21.47
P/FCF Ratio (TTM) 29.56 5.35
Price to 5YR AVG Earnings Ratio 34.96 -0.30
Price to 5YR AVG FCF Ratio 59.98 -7.28

Profitability (65%)

Company Industry
ROA (TTM) 9.65% -2.96%
ROE (TTM) 14.30% 23.42%
Net Profit Margin (TTM) 15.69% -894.56%
ROIC 5YR AVG 93.18% 16.62%

Growth (100%)

4QTR AVG 3YR AVG 5YR AVG
EPS 17.21% 92.99% 74.65%
Revenue 6.11% 6,798.64% 4,106.79%
Net Income 18.47% 93.88% 75.60%
Cash Flow 32.08% 99.61% 82.96%

Health (81%)

Company Industry
Current Ratio (TTM) 5.14 5.73
Quick Ratio (TTM) 4.94 5.45
D/E Ratio (TTM) 0.01 -14.53
Interest Coverage (TTM) 50.40 3.88
Piotroski F-Score 6 5
Altman Z-Score 16.81 13.58
LTL to 5YR AVG FCF 0.08 0.21
Shares Outstanding Growth 5YR AVG 0.71% 117.96%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙